Delivery Order SPE2DB20D3111-SPE2DB24FA8KL

Award Date 7/29/24
Potential Completion Date 7/30/24
Potential Value $8.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,768,511 Ondansetron ODT 8 mg tablets. The $6,593.91 firm fixed price contract has an ultimate completion date of September 12, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued at up to $999,999,999 and $750,000 respectively, for providing a wide range of medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,938.37 firm fixed-price contract is for the delivery of 4,567,472,969 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of March 6, 2025 and is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron ODT 4 mg tablets. The contract is a firm fixed-price delivery order with a ceiling value of $32,410.81 and a completion date of July 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,691.38 firm fixed price contract is for the delivery of Ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of January 31, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a large pharmaceutical distributor, for the supply of Ondansetron ODT 4 mg tablets. The delivery order, valued at $1,866.94, is a firm-fixed price contract with an ultimate completion date of August 6, 2024. It is not a set-aside contract. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999 and $750,000...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,255,117 units of Ondansetron ODT 4 mg tablets. The firm-fixed-price contract has a ceiling value of $3,609.81 and a completion date of February 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,778.69, is for the supply of Ondansetron ODT 8 mg tablets. The contract is a firm fixed-price delivery order with a completion date of January 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,517.18 firm fixed-price delivery order is for the supply of 4,566,249,434 units of ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of October 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,695.23, is for the delivery of Ondansetron ODT 4 mg tablets. This is a firm-fixed-price delivery order contract with a completion date of January 23, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,345.98 firm fixed-price contract is for the supply of Ondansetron HCL 4 mg tablets. The contract has an ultimate completion date of February 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB24FA8KL
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,691.37 firm-fixed-price contract is for the supply of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of July 30, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, to provide a wide range of pharmaceutical and medical products to support military treatment programs and facilities, as well as other government healthcare initiatives. This specific award appears to be a part of the company's broader contracting activities with the DLA to deliver critical pharmaceutical supplies. No set-aside designation is indicated.

Generated 10/28/24, 9:39 AM